Reevaluation of antibody titers 1 year after influenza vaccination in patients with rheumatoid arthritis receiving TNF blockers

Vol.19 No.2

Letter

Reevaluation of antibody titers 1 year after influenza vaccination in patients with rheumatoid arthritis receiving TNF blockers

Authors

Tokiko Nii¹ , Tetsuo Kubota¹ , Toshihiro Nanki² , Yukiko Komano² , Masayoshi Harigai² , Hitoshi Kohsaka³ , Wataru Hirose⁴ , Kenji Nagasaka⁵ , Tetsushi Sakurai⁶ , Nobuyuki Miyasaka³

Tokyo Medical and Dental University Graduate School of Health Sciences, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan
Department of Pharmacovigilance, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
Department of Medicine and Rheumatology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
Hirose Clinic, Tokorozawa, Japan
Ome Municipal General Hospital, Ome, Japan
Sakurai Clinic, Ome, Japan

Received:

8 September 2008

Accepted:

7 October 2008

Published online:

18 November 2008

Full Text

PDF　(member's only)

Abstract

Without Abstract

Key words

Influenza vaccine - Etanercept - Infliximab - Survival of plasma cells